What is the current size and annual growth rate of the sepsis market?
The sepsis market size has grown strongly in recent years. It will grow from $0.93 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increase in sepsis incidence due to aging populations, rise in prevalence of chronic diseases, growth in awareness of sepsis among healthcare providers, escalating healthcare expenditure, and implementation of government initiatives for early detection and management.
The sepsis market size is expected to see strong growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing adoption of artificial intelligence in critical care, rising prevalence of multidrug-resistant infections, growing awareness campaigns about sepsis, expanding healthcare infrastructure in emerging economies, and increasing investments in biotechnology and pharmaceutical research. Major trends in the forecast period include development of rapid point-of-care diagnostics, adoption of AI-driven predictive analytics, personalized antibiotic stewardship programs, advancements in blood culture techniques, innovative biomarker identification, and development of novel therapies targeting immune modulation.
Get Your Free Sample of The Global Sepsis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21286&type=smp
Which major factors have contributed to the expansion of the sepsis market?
The increasing burden of infectious diseases is expected to drive the growth of the sepsis market going forward. Infectious diseases are illnesses caused by bacteria, viruses, fungi, or parasites invading the body. Common infectious diseases include tuberculosis, flu, ringworm, and malaria, which spread through contact, contaminated sources, or insect vectors. The incidence of infectious diseases is due to growth, globalization, environmental changes, drug-resistant pathogens, and gaps in healthcare systems. Sepsis is a severe complication of infectious diseases that arises from the body’s extreme response to infections, leading to widespread inflammation and potential organ failure. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based government agency for public health, in 2023, the United States recorded 9,633 cases of tuberculosis(TB), marking a 15.6% rise from 8,332 cases reported in 2022. Therefore, the increasing burden of infectious diseases is driving the growth of the sepsis market.
How is the sepsis market segmented?
The sepsis market covered in this report is segmented –
1) By Type: Diagnosis, Therapeutics
2) By Pathogen: Bacterial, Viral, Fungal
3) By Application: Severe Sepsis, Septic Shock
4) By End User: Hospitals, Pathology, Reference Laboratories
Subsegments:
1) By Diagnosis: Blood Tests, Imaging Techniques, Microbiological Culture Tests, Biomarker Tests, Other Diagnostic Methods
2) By Therapeutics: Antibiotics, Antifungal Agents, Vasopressors, Immunoglobulins, Corticosteroids, Other Therapeutic Options
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/sepsis-global-market-report
Who are the top competitors in the sepsis market?
Major companies operating in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott laboratories, Novartis AG, Siemens AG, Asahi Kasei Corporation, Becton, Dickinson and Company, bioMérieux SA, QuidelOrtho Corporation, Diasorin S.p.A., Innoviva Inc., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.
Which key trends are expected to influence the sepsis market in the coming years?
Major companies operating in the sepsis market are focusing on developing technologically advanced platforms, such as artificial intelligence (AI)-powered platforms, to improve early diagnosis, enhance treatment precision, and predict patient outcomes, ultimately aiming to reduce mortality rates and improve healthcare efficiency in sepsis management. For instance, in June 2024, Predicate Healthcare Performance Group (HPG), a US-based healthcare company, launched its AI software platform, OpenDX, an innovative platform that combines AI-powered diagnostics with wearable biosensors, enabling healthcare providers to detect early signs of sepsis. This aids in sepsis diagnosis and has the potential to expand to other health conditions, highlighting the role of technology in diagnostics. Predicate’s chest sensor helps healthcare workers detect early sepsis signs, a challenging and often missed diagnosis.
Which regional trends are influencing the sepsis market, and which area dominates the industry?
North America was the largest region in the sepsis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Sepsis Market Report 2025 Offer?
The sepsis market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Sepsis is a life-threatening condition caused by the body’s extreme response to an infection. It occurs when the immune system releases chemicals into the bloodstream to fight the infection, but these chemicals trigger widespread inflammation, leading to tissue damage, organ failure, and potentially death.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21286
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
